US7375198B2
(en)
*
|
1993-10-26 |
2008-05-20 |
Affymetrix, Inc. |
Modified nucleic acid probes
|
US6475721B2
(en)
|
1995-03-04 |
2002-11-05 |
Boston Probes, Inc. |
Sequence specific detection of nucleic acids using a solid carrier bound with nucleic acid analog probes
|
GB9507238D0
(en)
*
|
1995-04-07 |
1995-05-31 |
Isis Innovation |
Detecting dna sequence variations
|
US6852487B1
(en)
*
|
1996-02-09 |
2005-02-08 |
Cornell Research Foundation, Inc. |
Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
|
US20020150921A1
(en)
*
|
1996-02-09 |
2002-10-17 |
Francis Barany |
Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
|
WO1997035033A1
(en)
|
1996-03-19 |
1997-09-25 |
Molecular Tool, Inc. |
Method for determining the nucleotide sequence of a polynucleotide
|
CA2255774C
(en)
|
1996-05-29 |
2008-03-18 |
Cornell Research Foundation, Inc. |
Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
|
US7070925B1
(en)
*
|
1996-07-16 |
2006-07-04 |
Gen-Probe Incorporated |
Method for determining the presence of an RNA analyte in a sample using a modified oligonucleotide probe
|
CA2260749A1
(en)
*
|
1996-07-16 |
1998-01-22 |
Gen-Probe Incorporated |
Methods for detecting rna analytes using modified probes
|
US6361940B1
(en)
|
1996-09-24 |
2002-03-26 |
Qiagen Genomics, Inc. |
Compositions and methods for enhancing hybridization and priming specificity
|
AU6646398A
(en)
*
|
1996-12-31 |
1998-07-31 |
Genometrix Incorporated |
Multiplexed molecular analysis apparatus and method
|
SE522077C2
(sv)
*
|
1997-09-05 |
2004-01-13 |
Lightup Technologies Ab |
Förfarande att välja sekvens hos sond för nukleinsyrahybridisering
|
US6518017B1
(en)
*
|
1997-10-02 |
2003-02-11 |
Oasis Biosciences Incorporated |
Combinatorial antisense library
|
US6723560B2
(en)
*
|
1998-10-08 |
2004-04-20 |
Mayo Foundation For Medical Education And Research |
Using polyamide nucleic acid oligomers to engender a biological response
|
US6989270B1
(en)
|
1997-10-17 |
2006-01-24 |
Mayo Foundation For Medical Education And Research |
Using polyamide nucleic acid oligomers to engender a biological response
|
US20100105572A1
(en)
*
|
1997-12-19 |
2010-04-29 |
Kris Richard M |
High throughput assay system
|
US20030039967A1
(en)
*
|
1997-12-19 |
2003-02-27 |
Kris Richard M. |
High throughput assay system using mass spectrometry
|
US20030096232A1
(en)
*
|
1997-12-19 |
2003-05-22 |
Kris Richard M. |
High throughput assay system
|
US6087102A
(en)
*
|
1998-01-07 |
2000-07-11 |
Clontech Laboratories, Inc. |
Polymeric arrays and methods for their use in binding assays
|
US6289229B1
(en)
|
1998-01-20 |
2001-09-11 |
Scimed Life Systems, Inc. |
Readable probe array for in vivo use
|
US20020090639A1
(en)
*
|
1998-02-26 |
2002-07-11 |
Mcginnis Ralph Evan |
Two dimensional linkage study methods and related inventions
|
US6077673A
(en)
*
|
1998-03-31 |
2000-06-20 |
Clontech Laboratories, Inc. |
Mouse arrays and kits comprising the same
|
US6683173B2
(en)
*
|
1998-04-03 |
2004-01-27 |
Epoch Biosciences, Inc. |
Tm leveling methods
|
US7715989B2
(en)
*
|
1998-04-03 |
2010-05-11 |
Elitech Holding B.V. |
Systems and methods for predicting oligonucleotide melting temperature (TmS)
|
CA2323638A1
(en)
*
|
1998-04-03 |
1999-10-14 |
Phylos, Inc. |
Addressable protein arrays
|
US7875440B2
(en)
|
1998-05-01 |
2011-01-25 |
Arizona Board Of Regents |
Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
|
US6780591B2
(en)
|
1998-05-01 |
2004-08-24 |
Arizona Board Of Regents |
Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
|
US6979728B2
(en)
|
1998-05-04 |
2005-12-27 |
Baylor College Of Medicine |
Articles of manufacture and methods for array based analysis of biological molecules
|
EP1092047B1
(de)
*
|
1998-07-02 |
2009-08-26 |
Gen-Probe Incorporated |
Molekulare fackeln
|
US6222030B1
(en)
*
|
1998-08-03 |
2001-04-24 |
Agilent Technologies, Inc. |
Solid phase synthesis of oligonucleotides using carbonate protecting groups and alpha-effect nucleophile deprotection
|
US6461812B2
(en)
|
1998-09-09 |
2002-10-08 |
Agilent Technologies, Inc. |
Method and multiple reservoir apparatus for fabrication of biomolecular arrays
|
US6475440B1
(en)
|
1998-09-16 |
2002-11-05 |
Clontech Laboratories, Inc. |
Applicator for use in deposition of fluid samples onto a substrate surface
|
US6087112A
(en)
*
|
1998-12-30 |
2000-07-11 |
Oligos Etc. Inc. |
Arrays with modified oligonucleotide and polynucleotide compositions
|
US6506594B1
(en)
*
|
1999-03-19 |
2003-01-14 |
Cornell Res Foundation Inc |
Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
|
WO2000070093A1
(en)
*
|
1999-05-13 |
2000-11-23 |
Oligos Etc. Inc. |
Arrays with modified oligonucleotide and polynucleotide compositions
|
KR100379411B1
(ko)
*
|
1999-06-28 |
2003-04-10 |
엘지전자 주식회사 |
바이오칩 및 그의 생체 물질 패터닝 및 측정 방법
|
US6818395B1
(en)
|
1999-06-28 |
2004-11-16 |
California Institute Of Technology |
Methods and apparatus for analyzing polynucleotide sequences
|
US6346423B1
(en)
|
1999-07-16 |
2002-02-12 |
Agilent Technologies, Inc. |
Methods and compositions for producing biopolymeric arrays
|
EP1072679A3
(de)
*
|
1999-07-20 |
2002-07-31 |
Agilent Technologies, Inc. (a Delaware corporation) |
Methode zur Herstelung von Nucleinsäuremolekülen mit einer reduzierten Sekundärstruktur
|
US20050118618A1
(en)
*
|
1999-08-30 |
2005-06-02 |
Dale Roderic M. |
Method for detecting nucleic acid sequences
|
US7244559B2
(en)
|
1999-09-16 |
2007-07-17 |
454 Life Sciences Corporation |
Method of sequencing a nucleic acid
|
US7211390B2
(en)
|
1999-09-16 |
2007-05-01 |
454 Life Sciences Corporation |
Method of sequencing a nucleic acid
|
US6844151B1
(en)
|
1999-09-29 |
2005-01-18 |
Oligos Etc. Inc. |
Methods for production of arrays with modified oligonucleotide and polynucleotide compositions
|
AU7742100A
(en)
*
|
1999-09-29 |
2001-04-30 |
Oligos Etc. Inc. |
Arrays with modified oligonucleotide and polynucleotide compositions
|
US20030190644A1
(en)
|
1999-10-13 |
2003-10-09 |
Andreas Braun |
Methods for generating databases and databases for identifying polymorphic genetic markers
|
US6171797B1
(en)
|
1999-10-20 |
2001-01-09 |
Agilent Technologies Inc. |
Methods of making polymeric arrays
|
US6958225B2
(en)
|
1999-10-27 |
2005-10-25 |
Affymetrix, Inc. |
Complexity management of genomic DNA
|
US6660845B1
(en)
|
1999-11-23 |
2003-12-09 |
Epoch Biosciences, Inc. |
Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
|
WO2001038585A2
(en)
*
|
1999-11-24 |
2001-05-31 |
The Regents Of The University Of California |
Polymer arrays and methods of using labeled probe molecules to identify and quantify target molecule expression
|
EP1111069A1
(de)
*
|
1999-12-22 |
2001-06-27 |
BioChip Technologies GmbH |
Modifizierte Nukleinsäuren und deren Verwendung
|
US6800439B1
(en)
|
2000-01-06 |
2004-10-05 |
Affymetrix, Inc. |
Methods for improved array preparation
|
EP1301600A2
(de)
*
|
2000-01-28 |
2003-04-16 |
Lexicon Genetics Incorporated |
Humane enzyme und polynukleotide, die dafür kodieren
|
US6489466B2
(en)
*
|
2000-01-28 |
2002-12-03 |
Linden Technologies, Inc. |
C-3′ protected monomeric nucleotides and synthesis of oligonucleotides on solid support
|
US6806361B1
(en)
|
2000-03-17 |
2004-10-19 |
Affymetrix, Inc. |
Methods of enhancing functional performance of nucleic acid arrays
|
US6833450B1
(en)
|
2000-03-17 |
2004-12-21 |
Affymetrix, Inc. |
Phosphite ester oxidation in nucleic acid array preparation
|
AU2001249701A1
(en)
*
|
2000-03-31 |
2001-10-15 |
The Regents Of The University Of California |
Dna analysis software
|
WO2001079548A2
(en)
|
2000-04-14 |
2001-10-25 |
Cornell Research Foundation, Inc. |
Method of designing addressable array for detection of nucleic acid sequence differences using ligase detection reaction
|
US20020028455A1
(en)
*
|
2000-05-03 |
2002-03-07 |
Laibinis Paul E. |
Methods and reagents for assembling molecules on solid supports
|
CN1592792B
(zh)
|
2000-05-19 |
2010-12-01 |
伊拉根生物科学公司 |
检测核酸的材料和方法
|
US20020120409A1
(en)
*
|
2000-05-19 |
2002-08-29 |
Affymetrix, Inc. |
Methods for gene expression analysis
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
YU92202A
(sh)
|
2000-05-26 |
2006-01-16 |
Idenix (Cayman) Limited |
Metode i smeše za lečenje flavi virusa i pesti virusa
|
US7005259B1
(en)
|
2000-06-01 |
2006-02-28 |
Affymetrix, Inc. |
Methods for array preparation using substrate rotation
|
EP1176151B1
(de)
|
2000-07-28 |
2014-08-20 |
Agilent Technologies, Inc. |
Synthese von Polynukleotiden unter Gebrauch von kombinierter Oxidations- und Entschützungschemie
|
WO2002012263A1
(en)
*
|
2000-08-03 |
2002-02-14 |
Roche Diagnostics Gmbh |
Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
|
US7494817B2
(en)
*
|
2000-09-06 |
2009-02-24 |
Transnet Yx, Inc. |
Methods for genotype screening using magnetic particles
|
US20050272085A1
(en)
*
|
2000-09-06 |
2005-12-08 |
Hodge Timothy A |
Methods for forensic and congenic screening
|
US20050239125A1
(en)
*
|
2000-09-06 |
2005-10-27 |
Hodge Timothy A |
Methods for genotype screening
|
EP1978110B1
(de)
*
|
2000-09-06 |
2010-05-26 |
Transnetyx, Inc. |
Computer-basiertes Verfahren und System zum Screenen von genomischer DNS
|
US20050266494A1
(en)
*
|
2000-09-06 |
2005-12-01 |
Hodge Timothy A |
System and method for computer network ordering of biological testing
|
US20030087286A1
(en)
*
|
2000-09-06 |
2003-05-08 |
Hodge Timothy A. |
Isolation of eukaryotic genomic DNA using magnetically responsive solid functionalized particles
|
US20030082605A1
(en)
*
|
2000-09-06 |
2003-05-01 |
Hodge Timothy A. |
Genomic DNA detection method and system thereof
|
US20040185464A1
(en)
*
|
2000-09-15 |
2004-09-23 |
Kris Richard M. |
High throughput assay system
|
AU1317502A
(en)
|
2000-10-14 |
2002-04-29 |
Eragen Biosciences Inc |
Solid support assay systems and methods utilizing non-standard bases
|
CN100385013C
(zh)
*
|
2000-10-14 |
2008-04-30 |
伊拉根生物科学公司 |
使用非标准碱基的固相支持体分析***和方法
|
US6849409B2
(en)
|
2000-10-16 |
2005-02-01 |
Axxima Pharmaceuticals Ag |
Cellular kinases involved in Cytomegalovirus infection and their inhibition
|
EP1368502A2
(de)
*
|
2001-02-13 |
2003-12-10 |
University of Rochester |
Alkynyliertes einzelstrang-oligonucleotid und seine verwendung
|
DE10112348A1
(de)
*
|
2001-03-13 |
2002-10-02 |
Antje Roetger |
Nukleotidträger zur Diagnose und Therapie oraler Erkrankungen
|
US20040038206A1
(en)
*
|
2001-03-14 |
2004-02-26 |
Jia Zhang |
Method for high throughput assay of genetic analysis
|
JP2004519247A
(ja)
*
|
2001-03-20 |
2004-07-02 |
オーソ・クリニカル・ダイアグノスティックス・インコーポレーテッド |
発現プロファイルおよび使用法
|
US6986992B2
(en)
*
|
2001-03-30 |
2006-01-17 |
Amersham Biosciences Ab |
P450 single nucleotide polymorphism biochip analysis
|
EP1251183A3
(de)
*
|
2001-04-18 |
2003-12-10 |
Exiqon A/S |
Verbesserte Helfersonden zur Detektion einer Zielsequenz mittels Fangoligonukleotid
|
NZ530460A
(en)
|
2001-06-21 |
2008-06-30 |
Dynavax Tech Corp |
Chimeric immunomodulatory compounds and methods of using the same
|
US7785610B2
(en)
|
2001-06-21 |
2010-08-31 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same—III
|
US7264964B2
(en)
*
|
2001-06-22 |
2007-09-04 |
Ceres, Inc. |
Chimeric histone acetyltransferase polypeptides
|
US20050147984A1
(en)
*
|
2001-08-31 |
2005-07-07 |
Clondiag Chip Technologies Gmbh |
Interaction detection on several probe arrays
|
EP1440311B1
(de)
*
|
2001-08-31 |
2009-01-07 |
Gen-Probe Incorporated |
Sonden mit affinitätsverschiebung zur quantifizierung von analytenpolynukleotiden
|
DE10142643A1
(de)
*
|
2001-08-31 |
2003-04-24 |
Clondiag Chip Tech Gmbh |
Detektion von Wechselwirkungen auf Sonden-Arrays
|
KR100809679B1
(ko)
*
|
2001-09-01 |
2008-03-06 |
삼성전자주식회사 |
혼성화된 핵산의 검출 및 신호 증폭 방법
|
US20060014186A1
(en)
*
|
2001-09-04 |
2006-01-19 |
Hodge Timothy A |
Methods for genotype screening of a strain disposed on an adsorbent carrier
|
DE10152925A1
(de)
*
|
2001-10-26 |
2003-05-08 |
Febit Ag |
Asymmetrische Sonden
|
US6858720B2
(en)
|
2001-10-31 |
2005-02-22 |
Agilent Technologies, Inc. |
Method of synthesizing polynucleotides using ionic liquids
|
US6852850B2
(en)
|
2001-10-31 |
2005-02-08 |
Agilent Technologies, Inc. |
Use of ionic liquids for fabrication of polynucleotide arrays
|
US20040067512A1
(en)
*
|
2001-11-09 |
2004-04-08 |
Neurogenetics, Inc. |
Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
|
US20110151438A9
(en)
|
2001-11-19 |
2011-06-23 |
Affymetrix, Inc. |
Methods of Analysis of Methylation
|
US20030211526A1
(en)
*
|
2002-02-15 |
2003-11-13 |
Jyh-Lyh Juang |
Cross-species nucleic acid probes
|
US20030162178A1
(en)
*
|
2002-02-25 |
2003-08-28 |
O'hagan David |
Variable microarray and methods of detecting one or more anlaytes in a sample
|
AU2003220159A1
(en)
*
|
2002-03-08 |
2003-09-22 |
Spectral Genomics, Inc. |
Articles of manufacture and methods for making hydrophobic derivatized arrays
|
US6916621B2
(en)
|
2002-03-27 |
2005-07-12 |
Spectral Genomics, Inc. |
Methods for array-based comparitive binding assays
|
US7687256B2
(en)
*
|
2002-04-11 |
2010-03-30 |
Spire Corporation |
Surface activated biochip
|
US20030198967A1
(en)
*
|
2002-04-23 |
2003-10-23 |
Matson Robert S. |
Multi-functional microarrays and methods
|
WO2003093296A2
(en)
*
|
2002-05-03 |
2003-11-13 |
Sequenom, Inc. |
Kinase anchor protein muteins, peptides thereof, and related methods
|
US20040014957A1
(en)
*
|
2002-05-24 |
2004-01-22 |
Anne Eldrup |
Oligonucleotides having modified nucleoside units
|
AU2003248748A1
(en)
|
2002-06-28 |
2004-01-19 |
Idenix (Cayman) Limited |
2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
NZ537662A
(en)
|
2002-06-28 |
2007-10-26 |
Idenix Cayman Ltd |
2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
FR2842827B1
(fr)
*
|
2002-07-26 |
2004-10-22 |
Biocortech |
NOUVELLE METHODE D'ANALYSE D'ACIDE NUCLEIQUE ET SON UTILISATION POUR EVALUER LE DEGRE D'EDITION DE L'ARNm DU RECEPTEUR 5-HT2c
|
US7901630B2
(en)
|
2002-08-20 |
2011-03-08 |
Illumina, Inc. |
Diffraction grating-based encoded microparticle assay stick
|
US7872804B2
(en)
|
2002-08-20 |
2011-01-18 |
Illumina, Inc. |
Encoded particle having a grating with variations in the refractive index
|
US7619819B2
(en)
|
2002-08-20 |
2009-11-17 |
Illumina, Inc. |
Method and apparatus for drug product tracking using encoded optical identification elements
|
US7508608B2
(en)
|
2004-11-17 |
2009-03-24 |
Illumina, Inc. |
Lithographically fabricated holographic optical identification element
|
US7923260B2
(en)
|
2002-08-20 |
2011-04-12 |
Illumina, Inc. |
Method of reading encoded particles
|
US7900836B2
(en)
|
2002-08-20 |
2011-03-08 |
Illumina, Inc. |
Optical reader system for substrates having an optically readable code
|
US7164533B2
(en)
|
2003-01-22 |
2007-01-16 |
Cyvera Corporation |
Hybrid random bead/chip based microarray
|
EP1546404A2
(de)
*
|
2002-09-11 |
2005-06-29 |
Exiqon A/S |
Nukleinsäurepopulation mit teilpopulation aus lna-oligomeren
|
US20100255603A9
(en)
|
2002-09-12 |
2010-10-07 |
Putnam Martin A |
Method and apparatus for aligning microbeads in order to interrogate the same
|
US7092160B2
(en)
|
2002-09-12 |
2006-08-15 |
Illumina, Inc. |
Method of manufacturing of diffraction grating-based optical identification element
|
US20040219565A1
(en)
|
2002-10-21 |
2004-11-04 |
Sakari Kauppinen |
Oligonucleotides useful for detecting and analyzing nucleic acids of interest
|
EP1572977B1
(de)
*
|
2002-11-15 |
2010-03-03 |
Gen-Probe Incorporated |
Test und zusammensetzungen zum nachweis von bacillus-anthracis-nukleinsäure
|
CN1849142A
(zh)
|
2002-11-15 |
2006-10-18 |
埃迪尼克斯(开曼)有限公司 |
2′-支链核苷和黄病毒突变
|
EP2112229A3
(de)
|
2002-11-25 |
2009-12-02 |
Sequenom, Inc. |
Verfahren zum Identifizieren des Brustkrebsrisikos und zugehörige Behandlungen
|
AU2003300901A1
(en)
|
2002-12-12 |
2004-06-30 |
Idenix (Cayman) Limited |
Process for the production of 2'-branched nucleosides
|
CA2513626C
(en)
|
2003-01-17 |
2013-03-19 |
Eragen Biosciences, Inc. |
Nucleic acid amplification using non-standard bases
|
WO2004078941A2
(en)
*
|
2003-03-06 |
2004-09-16 |
Oligo Engine, Inc. |
Modulation of gene expression using dna-rna hybrids
|
WO2004090153A2
(en)
|
2003-04-01 |
2004-10-21 |
Eragen Biosciences,Inc. |
Polymerase inhibitor and method of using same
|
CA2463719A1
(en)
*
|
2003-04-05 |
2004-10-05 |
F. Hoffmann-La Roche Ag |
Nucleotide analogs with six membered rings
|
US20040219532A1
(en)
*
|
2003-04-30 |
2004-11-04 |
Sampson Jeffrey R. |
Internal references measurements
|
JP2004337042A
(ja)
*
|
2003-05-14 |
2004-12-02 |
Canon Inc |
核酸アレイ
|
EP3521297B1
(de)
|
2003-05-30 |
2021-12-22 |
Gilead Pharmasset LLC |
Modifizierte fluorinierte nukleosidanaloga
|
WO2004111266A1
(en)
*
|
2003-06-17 |
2004-12-23 |
Human Genetic Signatures Pty Ltd |
Methods for genome amplification
|
WO2005003301A2
(en)
*
|
2003-06-17 |
2005-01-13 |
Signal Pharmaceuticals, Inc. |
Methods, compositions, and kits for predicting the effect of compounds on hot flash symptoms
|
US20040259100A1
(en)
|
2003-06-20 |
2004-12-23 |
Illumina, Inc. |
Methods and compositions for whole genome amplification and genotyping
|
US7642064B2
(en)
*
|
2003-06-24 |
2010-01-05 |
Ventana Medical Systems, Inc. |
Enzyme-catalyzed metal deposition for the enhanced detection of analytes of interest
|
CN1863927B
(zh)
*
|
2003-09-04 |
2010-08-11 |
人类遗传标记控股有限公司 |
核酸检测分析
|
GB0324851D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Expresson Biosystems Ltd |
Short biological polymers on solid supports
|
WO2005040163A1
(en)
*
|
2003-10-28 |
2005-05-06 |
Dr. Reddy's Laboratories Ltd |
Heterocyclic compounds that block the effects of advanced glycation end products (age)
|
US7169560B2
(en)
|
2003-11-12 |
2007-01-30 |
Helicos Biosciences Corporation |
Short cycle methods for sequencing polynucleotides
|
US7433123B2
(en)
|
2004-02-19 |
2008-10-07 |
Illumina, Inc. |
Optical identification element having non-waveguide photosensitive substrate with diffraction grating therein
|
EP1716254B1
(de)
|
2004-02-19 |
2010-04-07 |
Helicos Biosciences Corporation |
Verfahren zur analyse von polynukleotidsequenzen
|
US8168777B2
(en)
|
2004-04-29 |
2012-05-01 |
Human Genetic Signatures Pty. Ltd. |
Bisulphite reagent treatment of nucleic acid
|
US7702466B1
(en)
|
2004-06-29 |
2010-04-20 |
Illumina, Inc. |
Systems and methods for selection of nucleic acid sequence probes
|
JP4476050B2
(ja)
*
|
2004-06-30 |
2010-06-09 |
株式会社ニデック |
視野計
|
US8034554B2
(en)
*
|
2004-07-01 |
2011-10-11 |
Gen-Probe Incorporated |
Methods and compositions to detect nucleic acids in a biological sample
|
CN101023094B
(zh)
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
CA2574610A1
(en)
*
|
2004-07-22 |
2006-03-02 |
Sequenom, Inc. |
Methods for identifying risk of type ii diabetes and treatments thereof
|
ES2769377T3
(es)
|
2004-09-14 |
2020-06-25 |
Gilead Pharmasset Llc |
Intermedios de D-ribonolactona con sustitución de 2-fluoro-2-alquilo
|
ES2322175T3
(es)
|
2004-09-17 |
2009-06-17 |
EISAI R&D MANAGEMENT CO., LTD. |
Composicion medicinal con estabilidad mejorada y gelificacion reducida.
|
EP1645640B1
(de)
|
2004-10-05 |
2013-08-21 |
Affymetrix, Inc. |
Verfahren zur Detektion von chromosomalen Translokationen
|
CN101116086A
(zh)
|
2004-11-16 |
2008-01-30 |
伊路敏纳公司 |
读取编码微珠的方法和设备
|
EP1828411B1
(de)
*
|
2004-12-03 |
2012-11-07 |
Human Genetic Signatures PTY Ltd |
Verfahren zur vereinfachung mikrobieller nukleinsäuren durch chemische modifikation von cytosinen
|
AU2005318874B2
(en)
*
|
2004-12-23 |
2007-05-03 |
Human Genetic Signatures Pty Ltd |
Detection of human papilloma virus
|
MX2007008980A
(es)
*
|
2005-01-25 |
2008-01-14 |
Sky Genetics Inc |
Acidos nucleicos para apoptosis de celulas cancerigenas.
|
US20060183893A1
(en)
*
|
2005-01-25 |
2006-08-17 |
North Don A |
Nucleic acids for apoptosis of cancer cells
|
US20090215028A1
(en)
*
|
2005-02-18 |
2009-08-27 |
Ellen Paxinos |
Methods and Compositions for Determining Anti-HIV Drug Susceptibility and Replication Capacity of HIV
|
US8178291B2
(en)
|
2005-02-18 |
2012-05-15 |
Monogram Biosciences, Inc. |
Methods and compositions for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitors
|
JP4516863B2
(ja)
*
|
2005-03-11 |
2010-08-04 |
株式会社ケンウッド |
音声合成装置、音声合成方法及びプログラム
|
US7498136B2
(en)
|
2005-03-18 |
2009-03-03 |
Eragen Biosciences, Inc. |
Methods for detecting multiple species and subspecies of Neisseria
|
CN101203618B
(zh)
*
|
2005-05-26 |
2013-03-13 |
人类遗传标记控股有限公司 |
使用含有非常规碱基的引物的等温链置换扩增
|
WO2006130477A2
(en)
|
2005-05-27 |
2006-12-07 |
Monogram Biosciences, Inc. |
Methods and compositions for determining resistance of hiv-1 to protease inhibitors
|
US9506121B2
(en)
*
|
2005-06-06 |
2016-11-29 |
Monogram Biosciences, Inc. |
Methods for determining resistance or susceptibility to HIV entry inhibitors
|
US8071284B2
(en)
*
|
2005-06-06 |
2011-12-06 |
Monogram Biosciences, Inc. |
Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugs
|
CA2610863C
(en)
*
|
2005-06-07 |
2017-01-17 |
Eragen Biosciences, Inc. |
Methods for detection and typing of nucleic acids
|
EP3257949A1
(de)
|
2005-06-15 |
2017-12-20 |
Complete Genomics Inc. |
Nukleinsäureanalyse durch zufällige mischungen von nichtüberlappenden fragmenten
|
US20060292585A1
(en)
*
|
2005-06-24 |
2006-12-28 |
Affymetrix, Inc. |
Analysis of methylation using nucleic acid arrays
|
JP4989476B2
(ja)
|
2005-08-02 |
2012-08-01 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
血管新生阻害物質の効果を検定する方法
|
US7666593B2
(en)
|
2005-08-26 |
2010-02-23 |
Helicos Biosciences Corporation |
Single molecule sequencing of captured nucleic acids
|
CA2621932A1
(en)
*
|
2005-09-14 |
2007-03-22 |
Human Genetic Signatures Pty Ltd |
Assay for hpv and methylated genomic dna targets to screen for cervical cancer
|
US20070202515A1
(en)
*
|
2005-10-12 |
2007-08-30 |
Pathologica, Llc. |
Promac signature application
|
AU2006309551B2
(en)
|
2005-11-07 |
2012-04-19 |
Eisai R & D Management Co., Ltd. |
Use of combination of anti-angiogenic substance and c-kit kinase inhibitor
|
EP1976382B1
(de)
|
2005-12-23 |
2013-04-24 |
IDENIX Pharmaceuticals, Inc. |
Verfahren zur herstellung eines synthetischen zwischenprodukts für die herstellung von verzweigten nukleosiden
|
TW200745556A
(en)
*
|
2006-01-24 |
2007-12-16 |
Ind Tech Res Inst |
Biomarkers for liver fibrotic injury
|
US20080045471A1
(en)
*
|
2006-03-27 |
2008-02-21 |
North Don A |
Nucleic Acids For Apoptosis Of Cancer Cells
|
US7901882B2
(en)
|
2006-03-31 |
2011-03-08 |
Affymetrix, Inc. |
Analysis of methylation using nucleic acid arrays
|
US7830575B2
(en)
|
2006-04-10 |
2010-11-09 |
Illumina, Inc. |
Optical scanner with improved scan time
|
CN104706637A
(zh)
|
2006-05-18 |
2015-06-17 |
卫材R&D管理有限公司 |
针对甲状腺癌的抗肿瘤剂
|
EP2029777B1
(de)
|
2006-05-31 |
2017-03-08 |
Sequenom, Inc. |
Verfahren und zusammensetzungen zur nukleinsäureextraktion aus einer probe
|
US20080050738A1
(en)
*
|
2006-05-31 |
2008-02-28 |
Human Genetic Signatures Pty Ltd. |
Detection of target nucleic acid
|
WO2007140599A1
(en)
|
2006-06-05 |
2007-12-13 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
CN101511793B
(zh)
|
2006-08-28 |
2011-08-03 |
卫材R&D管理有限公司 |
针对未分化型胃癌的抗肿瘤剂
|
AU2007325931A1
(en)
|
2006-11-02 |
2008-06-05 |
Yale University |
Assessment of oocyte competence
|
DK2099935T3
(da)
*
|
2006-11-30 |
2014-04-07 |
Univ California |
Array for detektion af mikrober
|
US7902345B2
(en)
|
2006-12-05 |
2011-03-08 |
Sequenom, Inc. |
Detection and quantification of biomolecules using mass spectrometry
|
DE102007018833A1
(de)
|
2007-04-20 |
2008-10-23 |
Febit Holding Gmbh |
Verbesserte molekularbiologische Prozessanlage
|
DE102006062089A1
(de)
|
2006-12-29 |
2008-07-03 |
Febit Holding Gmbh |
Verbesserte molekularbiologische Prozessanlage
|
WO2008093855A1
(ja)
|
2007-01-29 |
2008-08-07 |
Eisai R & D Management Co., Ltd. |
未分化型胃癌治療用組成物
|
WO2008098142A2
(en)
|
2007-02-08 |
2008-08-14 |
Sequenom, Inc. |
Nucleic acid-based tests for rhd typing, gender determination and nucleic acid quantification
|
US9581595B2
(en)
|
2007-02-26 |
2017-02-28 |
Laboratory Corporation Of America Holdings |
Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy
|
AU2008222563A1
(en)
|
2007-03-05 |
2008-09-12 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
AU2008229628A1
(en)
*
|
2007-03-16 |
2008-09-25 |
Human Genetic Signatures Pty Ltd |
Assay for gene expression
|
AU2008230813B2
(en)
|
2007-03-26 |
2014-01-30 |
Sequenom, Inc. |
Restriction endonuclease enhanced polymorphic sequence detection
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
MX2009013410A
(es)
|
2007-06-08 |
2010-03-22 |
Biogen Idec Inc |
Biomarcadores para predecir capacidad de respuesta anti-tnf o sin capacidad de respuesta.
|
EP2195452B1
(de)
|
2007-08-29 |
2012-03-14 |
Sequenom, Inc. |
Verfahren und zusammensetzungen für die universelle grössenspezifische polymerasekettenreaktion
|
CA2704000C
(en)
*
|
2007-11-09 |
2016-12-13 |
Eisai R&D Management Co., Ltd. |
Combination of anti-angiogenic substance and anti-tumor platinum complex
|
CN101918595A
(zh)
|
2007-11-27 |
2010-12-15 |
人类遗传标记控股有限公司 |
用于扩增和复制亚硫酸氢盐修饰的核酸的酶
|
WO2009079703A1
(en)
*
|
2007-12-20 |
2009-07-02 |
Human Genetic Signatures Pty Ltd |
Elimination of contaminants associated with nucleic acid amplification
|
EP2271772B1
(de)
|
2008-03-11 |
2014-07-16 |
Sequenom, Inc. |
Tests auf nukleinsäurebasis zur pränatalen geschlechtsbestimmung
|
US8206926B2
(en)
|
2008-03-26 |
2012-06-26 |
Sequenom, Inc. |
Restriction endonuclease enhanced polymorphic sequence detection
|
EP2105465A1
(de)
*
|
2008-03-27 |
2009-09-30 |
Greene, Tweed Of Delaware, Inc. |
An ein inertes Substrat gebundene Perfluorelastomer-Bestandteile und zugehörige Verfahren
|
WO2009121021A1
(en)
*
|
2008-03-28 |
2009-10-01 |
Life Technologies Corporation |
Degradable arrays for preventing reuse
|
US20090269746A1
(en)
*
|
2008-04-25 |
2009-10-29 |
Gil Atzmon |
Microsequencer-whole genome sequencer
|
JP5733796B2
(ja)
*
|
2008-05-13 |
2015-06-10 |
ジェン−プロウブ インコーポレイテッド |
標的核酸配列の選択的ハイブリダイゼーションおよび捕捉における使用のため不活化可能型標的捕捉オリゴマー
|
US20110111417A1
(en)
|
2008-05-14 |
2011-05-12 |
Millennium Pharmaceuticals, Inc. |
Methods and kits for monitoring the effects of immunomodulators on adaptive immunity
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
CN102203282B
(zh)
|
2008-06-25 |
2014-04-30 |
生命技术公司 |
使用大规模fet阵列测量分析物的方法和装置
|
WO2010025340A2
(en)
|
2008-08-29 |
2010-03-04 |
Centocor Ortho Biotech Inc. |
Markers and methods for assessing and treating ulcerative colitis and related disorders using a 20 gene panel
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
US20120052066A1
(en)
|
2008-11-07 |
2012-03-01 |
Cesar Calderon |
Markers and methods for assessing and treating lupus patients susceptible to photoprovocation
|
CN102292457B
(zh)
|
2008-11-25 |
2014-04-09 |
简·探针公司 |
检测小rna的组合物和方法及其用途
|
PA8855801A1
(es)
|
2008-12-23 |
2010-07-27 |
|
Sintesis de nucleosidos de purina
|
WO2010075517A2
(en)
|
2008-12-23 |
2010-07-01 |
Pharmasset, Inc. |
Nucleoside analogs
|
NZ593648A
(en)
|
2008-12-23 |
2013-09-27 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
US8771948B2
(en)
|
2009-04-03 |
2014-07-08 |
Sequenom, Inc. |
Nucleic acid preparation compositions and methods
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
TWI576352B
(zh)
|
2009-05-20 |
2017-04-01 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
EP2456887B1
(de)
|
2009-07-21 |
2015-11-25 |
Gen-Probe Incorporated |
Verfahren und zusammensetzungen für den quantitativen nachweis von nukleinsäuresequenzen in einem erweiterten dynamischen bereich
|
WO2011050278A1
(en)
|
2009-10-23 |
2011-04-28 |
Eragen Biosciences, Inc. |
Amplification primers with non-standard bases for increased reaction specificity
|
ES2577017T3
(es)
|
2009-12-22 |
2016-07-12 |
Sequenom, Inc. |
Procedimientos y kits para identificar la aneuploidia
|
US9476868B2
(en)
|
2009-12-23 |
2016-10-25 |
Hill's Pet Nutrition, Inc. |
Compositions and methods for diagnosing and treating kidney disorders in a canine
|
US8563530B2
(en)
|
2010-03-31 |
2013-10-22 |
Gilead Pharmassel LLC |
Purine nucleoside phosphoramidate
|
ES2551944T3
(es)
|
2010-03-31 |
2015-11-24 |
Gilead Pharmasset Llc |
(S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihidropirimidin-1-(2H)-il)-4-fluoro-3-hidroxi-4-metiltetrahidrofuran-2-il)metoxi)(fenoxi)fosforil)amino)propanoato de isopropilo cristalino
|
WO2011146725A1
(en)
|
2010-05-19 |
2011-11-24 |
Bayer Healthcare Llc |
Biomarkers for a multikinase inhibitor
|
WO2011159942A1
(en)
|
2010-06-18 |
2011-12-22 |
Illumina, Inc. |
Conformational probes and methods for sequencing nucleic acids
|
EP2586443B1
(de)
|
2010-06-25 |
2016-03-16 |
Eisai R&D Management Co., Ltd. |
Antitumorwirkstoff mit verbindungen mit kinasehemmungswirkung in kombination
|
CN105061534A
(zh)
|
2010-09-22 |
2015-11-18 |
艾丽奥斯生物制药有限公司 |
取代的核苷酸类似物
|
WO2012058532A2
(en)
|
2010-10-28 |
2012-05-03 |
Yale University |
Methods and compositions for assessing and treating cancer
|
DK2643470T3
(en)
|
2010-11-24 |
2016-05-17 |
Univ Yale |
Preparations and methods for treating ischemic injury with D-DT
|
JP6069215B2
(ja)
|
2010-11-30 |
2017-02-01 |
ギリアド ファーマセット エルエルシー |
化合物
|
EP2813851B1
(de)
|
2011-02-24 |
2016-06-08 |
Hill's Pet Nutrition, Inc. |
Zusammensetzungen und Verfahren zur Diagnostizierung von Nierenerkrankungen bei Katzen
|
AU2012246490B2
(en)
|
2011-04-18 |
2016-08-04 |
Eisai R&D Management Co., Ltd. |
Therapeutic agent for tumor
|
EP2699903B1
(de)
|
2011-04-20 |
2018-07-18 |
Life Technologies Corporation |
Verfahren, zusammensetzungen und systeme zur probenablagerung
|
US8450061B2
(en)
|
2011-04-29 |
2013-05-28 |
Sequenom, Inc. |
Quantification of a minority nucleic acid species
|
US9945862B2
(en)
|
2011-06-03 |
2018-04-17 |
Eisai R&D Management Co., Ltd. |
Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
|
CN103597097B
(zh)
|
2011-06-15 |
2016-08-17 |
希尔氏宠物营养品公司 |
用于诊断和监测猫科动物的甲状腺功能亢进的组合物和方法
|
AU2011376698B2
(en)
|
2011-09-07 |
2014-07-17 |
Human Genetic Signatures Pty Ltd |
Molecular detection assay
|
JP6238900B2
(ja)
|
2011-10-28 |
2017-11-29 |
ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. |
Nae阻害物質に対する応答のバイオマーカー
|
EP2776586B1
(de)
|
2011-11-11 |
2018-03-07 |
Millennium Pharmaceuticals, Inc. |
Biomarker der reaktion auf proteasomenhemmer
|
JP6397765B2
(ja)
|
2011-11-11 |
2018-09-26 |
ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. |
プロテアソーム阻害剤に応答するバイオマーカー
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
WO2013082448A1
(en)
|
2011-12-01 |
2013-06-06 |
University Of Kansas |
Methods for detecting trisomy 21
|
WO2013087789A1
(en)
|
2011-12-13 |
2013-06-20 |
Glykos Finland Ltd. |
Antibody isoform arrays and methods thereof
|
AU2012355775B2
(en)
|
2011-12-19 |
2015-10-08 |
Hill's Pet Nutrition, Inc. |
Compositions and methods for diagnosing and treating hyperthyroidism in companion animals
|
US8980865B2
(en)
|
2011-12-22 |
2015-03-17 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
EP3401399B1
(de)
|
2012-03-02 |
2020-04-22 |
Sequenom, Inc. |
Verfahren und prozesse zur nicht-invasiven beurteilung genetischer variationen
|
US8916538B2
(en)
|
2012-03-21 |
2014-12-23 |
Vertex Pharmaceuticals Incorporated |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
EP2827876A4
(de)
|
2012-03-22 |
2015-10-28 |
Alios Biopharma Inc |
Pharmazeutische kombinationen mit einem thionucleotidanalog
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
US9012022B2
(en)
|
2012-06-08 |
2015-04-21 |
Illumina, Inc. |
Polymer coatings
|
WO2014011928A1
(en)
|
2012-07-13 |
2014-01-16 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
JP6382192B2
(ja)
|
2012-07-16 |
2018-08-29 |
イエール ユニバーシティ |
疾患および障害を検出、治療、および予防するための組成物および方法
|
CN104822844B
(zh)
|
2012-10-01 |
2019-05-07 |
米伦纽姆医药公司 |
预测对抑制剂的反应的生物标记物和方法以及其用途
|
WO2014085216A1
(en)
|
2012-11-28 |
2014-06-05 |
Merck Sharp & Dohme Corp. |
Compositions and methods for treating cancer
|
US9334239B2
(en)
|
2012-12-21 |
2016-05-10 |
Eisai R&D Management Co., Ltd. |
Amorphous form of quinoline derivative, and method for producing same
|
US9896728B2
(en)
|
2013-01-29 |
2018-02-20 |
Arcticrx Ltd. |
Method for determining a therapeutic approach for the treatment of age-related macular degeneration (AMD)
|
JP6894664B2
(ja)
|
2013-02-13 |
2021-06-30 |
イエール ユニバーシティ |
病的な石灰化および骨化を治療するための組成物および方法
|
US11060145B2
(en)
|
2013-03-13 |
2021-07-13 |
Sequenom, Inc. |
Methods and compositions for identifying presence or absence of hypermethylation or hypomethylation locus
|
BR112015022448B1
(pt)
|
2013-03-15 |
2020-12-08 |
Illumina Cambridge Limited |
molécula de nucleotídeo ou nucleosídeo modificado, métodos para preparar o crescimento de polinucleotídeo complementar a polinucleotídeo alvo de fita simples em reação de sequenciação e para determinar a sequência de polinucleotídeo alvo de fita simples e kit
|
AU2014266223B2
(en)
|
2013-05-14 |
2020-06-25 |
Eisai R&D Management Co., Ltd. |
Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
|
DK3431614T3
(da)
|
2013-07-01 |
2021-12-06 |
Illumina Inc |
Katalysator fri overfladefunktionalisering og polymerpodning
|
CN107318267B
(zh)
|
2013-08-12 |
2021-08-17 |
豪夫迈·罗氏有限公司 |
用于治疗补体相关的病症的组合物和方法
|
ES2900570T3
(es)
|
2013-08-27 |
2022-03-17 |
Gilead Pharmasset Llc |
Formulación de combinación de dos compuestos antivirales
|
EP3068541B1
(de)
|
2013-11-11 |
2020-10-28 |
Life Technologies Corporation |
Rotoranordnung und verfahren zur verwendung
|
WO2015094992A1
(en)
|
2013-12-17 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Ifn-gamma gene signature biomarkers of tumor response to pd-1 antagonists
|
EP3572875A1
(de)
|
2013-12-19 |
2019-11-27 |
Illumina, Inc. |
Roll-to-roll-verfahren zur herstellung eines strukturierten substrats und mittels diesem verfahren hergestelltes strukturiertes substrat
|
CN112826930A
(zh)
|
2014-02-08 |
2021-05-25 |
豪夫迈·罗氏有限公司 |
治疗阿尔茨海默氏病的方法
|
EP3736344A1
(de)
|
2014-03-13 |
2020-11-11 |
Sequenom, Inc. |
Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
|
EP3142688B1
(de)
|
2014-05-16 |
2021-10-06 |
Yale University |
Zusammensetzungen zur behandlung und prävention von pankreatitis und nierenläsion
|
GB201414098D0
(en)
|
2014-08-08 |
2014-09-24 |
Illumina Cambridge Ltd |
Modified nucleotide linkers
|
EP3183577B1
(de)
|
2014-08-21 |
2020-08-19 |
Illumina Cambridge Limited |
Reversible oberflächenfunktionalisierung
|
PL3524595T3
(pl)
|
2014-08-28 |
2022-10-31 |
Eisai R&D Management Co., Ltd. |
Pochodna chinoliny o wysokiej czystości i sposób jej wytwarzania
|
JP6759197B2
(ja)
|
2014-10-31 |
2020-09-23 |
イルミナ ケンブリッジ リミテッド |
新規のポリマーおよびdnaコポリマーコーティング
|
RU2017123117A
(ru)
|
2014-12-09 |
2019-01-10 |
Мерк Шарп И Доум Корп. |
Система и способы получения биомаркеров генных сигнатур ответа на антагонисты pd-1
|
EP3250588A1
(de)
|
2015-01-29 |
2017-12-06 |
Board of Trustees of Michigan State University |
Kryptische polypeptide und verwendungen davon
|
HUE064614T2
(hu)
|
2015-02-25 |
2024-04-28 |
Eisai R&D Man Co Ltd |
Eljárás egy kinolin-származék keserû ízének elnyomására
|
MA41629A
(fr)
|
2015-03-04 |
2018-01-09 |
Center For Human Reproduction |
Compositions et méthodes d'utilisation de l'hormone anti-müllérienne pour le traitement de l'infertilité
|
KR20240064733A
(ko)
|
2015-03-04 |
2024-05-13 |
머크 샤프 앤드 돔 코포레이션 |
암을 치료하기 위한 pd-1 길항제 및 vegfr/fgfr/ret 티로신 키나제 억제제의 조합
|
EP3839510A3
(de)
|
2015-04-17 |
2021-08-25 |
Merck Sharp & Dohme Corp. |
Blutbasierte biomarker der tumorempfindlichkeit gegen pd-1-antagonisten
|
JP6995627B2
(ja)
|
2015-05-19 |
2022-02-04 |
イエール ユニバーシティ |
病的石灰化状態を治療するための組成物およびそれを使用する方法
|
BR112017027227B1
(pt)
|
2015-06-16 |
2023-12-12 |
Eisai R&D Management Co., Ltd |
Agente anti-câncer
|
EP3325648B1
(de)
|
2015-07-17 |
2023-03-29 |
Illumina, Inc. |
Polymerfolien zur sequenzierung von anwendungen
|
RU2706203C1
(ru)
|
2015-10-18 |
2019-11-14 |
Эффиметрикс, Инк. |
Мультиаллельное генотипирование однонуклеотидных полиморфизмов и индел-мутаций
|
EP3368692B1
(de)
|
2015-10-29 |
2021-07-21 |
Temple University Of The Commonwealth System Of Higher Education |
Modifizierung von 3'-endstücken von nukleinsäuren durch dna-polymerase-theta
|
EP4079322A1
(de)
|
2015-11-20 |
2022-10-26 |
Yale University |
Zusammensetzungen zur behandlung von ektopischen verkalkungsstörungen und verfahren damit
|
ES2861478T3
(es)
|
2016-05-18 |
2021-10-06 |
Illumina Inc |
Estampación de autoensamblado que utiliza superficies hidrófobas estampadas
|
WO2018098241A1
(en)
|
2016-11-22 |
2018-05-31 |
University Of Rochester |
Methods of assessing risk of recurrent prostate cancer
|
CA3057157A1
(en)
|
2017-04-28 |
2018-11-01 |
Merck Sharp & Dohme Corp. |
Biomarkers for cancer therapeutics
|
EP3625248A4
(de)
|
2017-05-18 |
2021-01-20 |
The Rockefeller University |
Zusammensetzungen und verfahren zur diagnose und behandlung von erkrankungen und leiden im zusammenhang mit kcnj5-mutationen
|
US20200377958A1
(en)
|
2017-12-01 |
2020-12-03 |
Millennium Pharmaceuticals, Inc. |
Biomarkers and methods for treatment with nae inhibitors
|
WO2019126472A1
(en)
|
2017-12-22 |
2019-06-27 |
Genentech, Inc. |
Use of pilra binding agents for treatment of a disease
|
MX2020007852A
(es)
|
2018-01-25 |
2021-01-29 |
Biogen Ma Inc |
Metodos para el tratamiento de la atrofia muscular espinal.
|
GB201803240D0
(en)
|
2018-02-28 |
2018-04-11 |
Synpromics Ltd |
Methods and compositions for enriching nucleic acids
|
WO2020071457A1
(en)
|
2018-10-05 |
2020-04-09 |
Eisai R&D Management Co., Ltd. |
Biomarkers for a combination therapy comprising lenvatinib and everolimus
|
WO2020071451A1
(en)
|
2018-10-05 |
2020-04-09 |
Eisai R&D Management Co., Ltd. |
Biomarkers for a therapy comprising a sorafenib compound
|
US11293061B2
(en)
|
2018-12-26 |
2022-04-05 |
Illumina Cambridge Limited |
Sequencing methods using nucleotides with 3′ AOM blocking group
|
US20220128578A1
(en)
|
2019-02-12 |
2022-04-28 |
Biogen Ma Inc. |
Biomarkers of progressive multifocal leukoencephalopathy
|
US11421271B2
(en)
|
2019-03-28 |
2022-08-23 |
Illumina Cambridge Limited |
Methods and compositions for nucleic acid sequencing using photoswitchable labels
|
GB201916884D0
(en)
|
2019-11-20 |
2020-01-01 |
Evox Therapeutics Ltd |
Nanoparticle-like delivery system
|
US11787831B2
(en)
|
2020-06-22 |
2023-10-17 |
Illumina Cambridge Limited |
Nucleosides and nucleotides with 3′ acetal blocking group
|
GB202010278D0
(en)
|
2020-07-03 |
2020-08-19 |
Evox Therapeutics Ltd |
Extracellular vesicles with improved half-life
|
US11981964B2
(en)
|
2020-07-28 |
2024-05-14 |
Illumina Cambridge Limited |
Substituted coumarin dyes and uses as fluorescent labels
|
WO2022094473A1
(en)
|
2020-11-02 |
2022-05-05 |
Simcha IL-18, Inc. |
Interleukin-18 variants and methods of use
|
US20220195517A1
(en)
|
2020-12-17 |
2022-06-23 |
Illumina Cambridge Limited |
Long stokes shift chromenoquinoline dyes and uses in sequencing applications
|
US20220195516A1
(en)
|
2020-12-17 |
2022-06-23 |
Illumina Cambridge Limited |
Methods, systems and compositions for nucleic acid sequencing
|
US20220195196A1
(en)
|
2020-12-17 |
2022-06-23 |
Illumina Cambridge Limited |
Alkylpyridinium coumarin dyes and uses in sequencing applications
|
US20220195518A1
(en)
|
2020-12-22 |
2022-06-23 |
Illumina Cambridge Limited |
Methods and compositions for nucleic acid sequencing
|
GB2603203A
(en)
|
2021-02-02 |
2022-08-03 |
Univ Heriot Watt |
Method for enriching nucelic acids
|
GB202105925D0
(en)
|
2021-04-26 |
2021-06-09 |
Evox Therapeutics Ltd |
Modified extracellular vesicles (EVs) with improved half-life
|
AU2022269804A1
(en)
|
2021-05-05 |
2023-11-02 |
Illumina Cambridge Limited |
Fluorescent dyes containing bis-boron fused heterocycles and uses in sequencing
|
GB202107182D0
(en)
|
2021-05-19 |
2021-06-30 |
Evox Therapeutics Ltd |
Nanoparticle delivery system for production of engineered extracellular vesicles
|
BR112023024130A2
(pt)
|
2021-05-20 |
2024-01-30 |
Illumina Cambridge Ltd |
Composições e métodos para sequenciamento por síntese
|
CN117677435A
(zh)
|
2021-06-15 |
2024-03-08 |
伊鲁米纳公司 |
用于测序的不含水凝胶的表面官能化
|
CN117813391A
(zh)
|
2021-07-23 |
2024-04-02 |
因美纳有限公司 |
制备用于dna测序的基底表面的方法
|
CA3234961A1
(en)
|
2021-10-20 |
2023-04-27 |
Illumina, Inc. |
Methods for capturing library dna for sequencing
|
GB202118946D0
(en)
|
2021-12-23 |
2022-02-09 |
Evox Therapeutics Ltd |
Engineered extracellular vesicles with improved cargo delivery
|
CA3222807A1
(en)
|
2022-03-22 |
2023-09-28 |
Alexandra SZEMJONOV |
Substrate with orthogonally functional nanodomains
|
CA3223115A1
(en)
|
2022-03-28 |
2023-10-05 |
Xiaolin Wu |
Labeled avidin and methods for sequencing
|
US20230314322A1
(en)
|
2022-03-29 |
2023-10-05 |
Illumina, Inc. |
Systems and methods of sequencing polynucleotides
|
WO2023213979A1
(en)
|
2022-05-06 |
2023-11-09 |
Evox Therapeutics Limited |
Tspan2 as scaffold protein for engineered extracellular vesicles
|
US20230383342A1
(en)
|
2022-05-31 |
2023-11-30 |
Illumina Cambridge Limited |
Compositions and methods for nucleic acid sequencing
|
WO2024003087A1
(en)
|
2022-06-28 |
2024-01-04 |
Illumina, Inc. |
Fluorescent dyes containing fused tetracyclic bis-boron heterocycle and uses in sequencing
|
GB202210861D0
(en)
|
2022-07-25 |
2022-09-07 |
Univ Oxford Innovation Ltd |
Loaded extracellular vesicle
|
WO2024039516A1
(en)
|
2022-08-19 |
2024-02-22 |
Illumina, Inc. |
Third dna base pair site-specific dna detection
|